Trends in utilization of stored cryopreserved autologous peripheral hematopoietic cells intended for a second (or beyond) autologous hematopoietic cell transplantation in patients with multiple myeloma: a single center experience

Due to the advent of effective novel therapies for multiple myeloma (MM), the use of cryopreserved autologous peripheral blood hematopoietic cells (APBHC) for a salvage autologous transplant (auto-HCT) is in decline. We evaluated utilization trends and costs associated with cryopreserved APBHC in pa...

Full description

Saved in:
Bibliographic Details
Published in:Bone marrow transplantation (Basingstoke) 2023-10, Vol.58 (10), p.1130-1136
Main Authors: Yassine, Farah, Kharfan-Dabaja, Mohamed A, Tsalantsanis, Athanasios, Roy, Vivek, Zubair, Abba C, Murthy, Hemant S, Ayala, Ernesto, Iqbal, Madiha, Sher, Taimur, Ailawadhi, Sikander, Parrondo, Ricardo D
Format: Article
Language:English
Subjects:
Apheresis
Autografts
Bone marrow
Costs
Cryopreservation
Hematopoietic stem cells
Multiple myeloma
Patients
Peripheral blood
Stem cell transplantation
Sums
Transplantation
Transplants & implants
Trends
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c431t-7c37dab6720f76a09aa478ee950e8c8b1250d4ba375360614f31d0bbb3efcb713
cites cdi_FETCH-LOGICAL-c431t-7c37dab6720f76a09aa478ee950e8c8b1250d4ba375360614f31d0bbb3efcb713
container_end_page 1136
container_issue 10
container_start_page 1130
container_title Bone marrow transplantation (Basingstoke)
container_volume 58
creator Yassine, Farah
Kharfan-Dabaja, Mohamed A
Tsalantsanis, Athanasios
Roy, Vivek
Zubair, Abba C
Murthy, Hemant S
Ayala, Ernesto
Iqbal, Madiha
Sher, Taimur
Ailawadhi, Sikander
Parrondo, Ricardo D
description Due to the advent of effective novel therapies for multiple myeloma (MM), the use of cryopreserved autologous peripheral blood hematopoietic cells (APBHC) for a salvage autologous transplant (auto-HCT) is in decline. We evaluated utilization trends and costs associated with cryopreserved APBHC in patients with MM. We retrospectively evaluated the clinicopathologic data from 440 patients with MM who underwent APBHC mobilization and collection at Mayo Clinic Florida between 2010 and 2019. Based on institution-specific charges as of May 2021, the cost of 1 session of APBHC collection/apheresis was $4,680 and the cost of 1 year of APBHC cryopreservation was $4,790 per patient. Out of 347 patients who had APBHC in cryopreservation, 5 (1.4%) underwent a salvage auto-HCT and 61% of patients had ≥1 excess collection sessions for APBHC that ultimately went unused. The median cost of excess collection sessions was $4,680 per patient (range, $4,680-$32,760) and the median total cost for excess collection sessions plus costs for storage was $23,840 per patient (range, $4,680-$85,450). The sum of costs of excess collection sessions was $2,077,920 and the sum of costs of cryopreservation was $5,812,665. Institutional policies regarding universal APBHC collection and long-term storage should be reevaluated in the era of novel therapeutics.
doi_str_mv 10.1038/s41409-023-02035-y
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10555832</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2841021263</sourcerecordid><originalsourceid>FETCH-LOGICAL-c431t-7c37dab6720f76a09aa478ee950e8c8b1250d4ba375360614f31d0bbb3efcb713</originalsourceid><addsrcrecordid>eNplUk2P1SAUbYzGeY7-AReGxM24qEKB0roxZuJXMombcU0ovX2PSQsV6Gj9v_4Pb33jZNQFgQvnHs49OUXxlNGXjPLmVRJM0LakFcdFuSzXe8WOCVWXktfyfrGjVd2UnNftSfEopStKmRBUPixOuBKqVZLvip-XEXyfiPNkyW50P0x2wZMwkJRDhJ7YuIY5QoJ4jZVZchjDPiyJzBDdfIBoRnKAyeQwBwfZWWJhHDfCjMTYMoRIDElgg-_JGRYdrHh8cZfrfwKSo_FpHo3PR0UocMYT-JzIN5cPZFrG7OYRyLTCGCbzevvF-T3eWERBJPB90wjewuPiwWDGBE9u9tPiy_t3l-cfy4vPHz6dv70oreAsl8py1ZuuVhUdVG1oa4xQDUArKTS26VglaS86w9G6mtZMDJz1tOs6DoPtFOOnxZsj77x0E_SbDvRHz9FNJq46GKf_fvHuoPfhWjMqpWx4hQxnNwwxfF0gZT25tBliPKBTumoEoxWrao7Q5_9Ar8ISPc6HKMUxIq1UiKqOKBtDShGGWzWM6i1G-hgjjTHSv2OkV2x6dneO25Y_ueG_AOq6zIM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2873103957</pqid></control><display><type>article</type><title>Trends in utilization of stored cryopreserved autologous peripheral hematopoietic cells intended for a second (or beyond) autologous hematopoietic cell transplantation in patients with multiple myeloma: a single center experience</title><source>Nexis UK</source><source>Springer Link</source><creator>Yassine, Farah ; Kharfan-Dabaja, Mohamed A ; Tsalantsanis, Athanasios ; Roy, Vivek ; Zubair, Abba C ; Murthy, Hemant S ; Ayala, Ernesto ; Iqbal, Madiha ; Sher, Taimur ; Ailawadhi, Sikander ; Parrondo, Ricardo D</creator><creatorcontrib>Yassine, Farah ; Kharfan-Dabaja, Mohamed A ; Tsalantsanis, Athanasios ; Roy, Vivek ; Zubair, Abba C ; Murthy, Hemant S ; Ayala, Ernesto ; Iqbal, Madiha ; Sher, Taimur ; Ailawadhi, Sikander ; Parrondo, Ricardo D</creatorcontrib><description>Due to the advent of effective novel therapies for multiple myeloma (MM), the use of cryopreserved autologous peripheral blood hematopoietic cells (APBHC) for a salvage autologous transplant (auto-HCT) is in decline. We evaluated utilization trends and costs associated with cryopreserved APBHC in patients with MM. We retrospectively evaluated the clinicopathologic data from 440 patients with MM who underwent APBHC mobilization and collection at Mayo Clinic Florida between 2010 and 2019. Based on institution-specific charges as of May 2021, the cost of 1 session of APBHC collection/apheresis was $4,680 and the cost of 1 year of APBHC cryopreservation was $4,790 per patient. Out of 347 patients who had APBHC in cryopreservation, 5 (1.4%) underwent a salvage auto-HCT and 61% of patients had ≥1 excess collection sessions for APBHC that ultimately went unused. The median cost of excess collection sessions was $4,680 per patient (range, $4,680-$32,760) and the median total cost for excess collection sessions plus costs for storage was $23,840 per patient (range, $4,680-$85,450). The sum of costs of excess collection sessions was $2,077,920 and the sum of costs of cryopreservation was $5,812,665. Institutional policies regarding universal APBHC collection and long-term storage should be reevaluated in the era of novel therapeutics.</description><identifier>ISSN: 0268-3369</identifier><identifier>ISSN: 1476-5365</identifier><identifier>EISSN: 1476-5365</identifier><identifier>DOI: 10.1038/s41409-023-02035-y</identifier><identifier>PMID: 37479753</identifier><language>eng</language><publisher>England: Nature Publishing Group</publisher><subject>Apheresis ; Autografts ; Bone marrow ; Costs ; Cryopreservation ; Hematopoietic stem cells ; Multiple myeloma ; Patients ; Peripheral blood ; Stem cell transplantation ; Sums ; Transplantation ; Transplants &amp; implants ; Trends</subject><ispartof>Bone marrow transplantation (Basingstoke), 2023-10, Vol.58 (10), p.1130-1136</ispartof><rights>2023. The Author(s).</rights><rights>The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c431t-7c37dab6720f76a09aa478ee950e8c8b1250d4ba375360614f31d0bbb3efcb713</citedby><cites>FETCH-LOGICAL-c431t-7c37dab6720f76a09aa478ee950e8c8b1250d4ba375360614f31d0bbb3efcb713</cites><orcidid>0000-0002-9314-9933 ; 0000-0002-8377-8111 ; 0000-0002-5950-4620 ; 0000-0003-4827-4740 ; 0000-0001-7394-5185 ; 0000-0001-6752-5440</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,786,790,891,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37479753$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yassine, Farah</creatorcontrib><creatorcontrib>Kharfan-Dabaja, Mohamed A</creatorcontrib><creatorcontrib>Tsalantsanis, Athanasios</creatorcontrib><creatorcontrib>Roy, Vivek</creatorcontrib><creatorcontrib>Zubair, Abba C</creatorcontrib><creatorcontrib>Murthy, Hemant S</creatorcontrib><creatorcontrib>Ayala, Ernesto</creatorcontrib><creatorcontrib>Iqbal, Madiha</creatorcontrib><creatorcontrib>Sher, Taimur</creatorcontrib><creatorcontrib>Ailawadhi, Sikander</creatorcontrib><creatorcontrib>Parrondo, Ricardo D</creatorcontrib><title>Trends in utilization of stored cryopreserved autologous peripheral hematopoietic cells intended for a second (or beyond) autologous hematopoietic cell transplantation in patients with multiple myeloma: a single center experience</title><title>Bone marrow transplantation (Basingstoke)</title><addtitle>Bone Marrow Transplant</addtitle><description>Due to the advent of effective novel therapies for multiple myeloma (MM), the use of cryopreserved autologous peripheral blood hematopoietic cells (APBHC) for a salvage autologous transplant (auto-HCT) is in decline. We evaluated utilization trends and costs associated with cryopreserved APBHC in patients with MM. We retrospectively evaluated the clinicopathologic data from 440 patients with MM who underwent APBHC mobilization and collection at Mayo Clinic Florida between 2010 and 2019. Based on institution-specific charges as of May 2021, the cost of 1 session of APBHC collection/apheresis was $4,680 and the cost of 1 year of APBHC cryopreservation was $4,790 per patient. Out of 347 patients who had APBHC in cryopreservation, 5 (1.4%) underwent a salvage auto-HCT and 61% of patients had ≥1 excess collection sessions for APBHC that ultimately went unused. The median cost of excess collection sessions was $4,680 per patient (range, $4,680-$32,760) and the median total cost for excess collection sessions plus costs for storage was $23,840 per patient (range, $4,680-$85,450). The sum of costs of excess collection sessions was $2,077,920 and the sum of costs of cryopreservation was $5,812,665. Institutional policies regarding universal APBHC collection and long-term storage should be reevaluated in the era of novel therapeutics.</description><subject>Apheresis</subject><subject>Autografts</subject><subject>Bone marrow</subject><subject>Costs</subject><subject>Cryopreservation</subject><subject>Hematopoietic stem cells</subject><subject>Multiple myeloma</subject><subject>Patients</subject><subject>Peripheral blood</subject><subject>Stem cell transplantation</subject><subject>Sums</subject><subject>Transplantation</subject><subject>Transplants &amp; implants</subject><subject>Trends</subject><issn>0268-3369</issn><issn>1476-5365</issn><issn>1476-5365</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNplUk2P1SAUbYzGeY7-AReGxM24qEKB0roxZuJXMombcU0ovX2PSQsV6Gj9v_4Pb33jZNQFgQvnHs49OUXxlNGXjPLmVRJM0LakFcdFuSzXe8WOCVWXktfyfrGjVd2UnNftSfEopStKmRBUPixOuBKqVZLvip-XEXyfiPNkyW50P0x2wZMwkJRDhJ7YuIY5QoJ4jZVZchjDPiyJzBDdfIBoRnKAyeQwBwfZWWJhHDfCjMTYMoRIDElgg-_JGRYdrHh8cZfrfwKSo_FpHo3PR0UocMYT-JzIN5cPZFrG7OYRyLTCGCbzevvF-T3eWERBJPB90wjewuPiwWDGBE9u9tPiy_t3l-cfy4vPHz6dv70oreAsl8py1ZuuVhUdVG1oa4xQDUArKTS26VglaS86w9G6mtZMDJz1tOs6DoPtFOOnxZsj77x0E_SbDvRHz9FNJq46GKf_fvHuoPfhWjMqpWx4hQxnNwwxfF0gZT25tBliPKBTumoEoxWrao7Q5_9Ar8ISPc6HKMUxIq1UiKqOKBtDShGGWzWM6i1G-hgjjTHSv2OkV2x6dneO25Y_ueG_AOq6zIM</recordid><startdate>20231001</startdate><enddate>20231001</enddate><creator>Yassine, Farah</creator><creator>Kharfan-Dabaja, Mohamed A</creator><creator>Tsalantsanis, Athanasios</creator><creator>Roy, Vivek</creator><creator>Zubair, Abba C</creator><creator>Murthy, Hemant S</creator><creator>Ayala, Ernesto</creator><creator>Iqbal, Madiha</creator><creator>Sher, Taimur</creator><creator>Ailawadhi, Sikander</creator><creator>Parrondo, Ricardo D</creator><general>Nature Publishing Group</general><general>Nature Publishing Group UK</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QP</scope><scope>7T5</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9314-9933</orcidid><orcidid>https://orcid.org/0000-0002-8377-8111</orcidid><orcidid>https://orcid.org/0000-0002-5950-4620</orcidid><orcidid>https://orcid.org/0000-0003-4827-4740</orcidid><orcidid>https://orcid.org/0000-0001-7394-5185</orcidid><orcidid>https://orcid.org/0000-0001-6752-5440</orcidid></search><sort><creationdate>20231001</creationdate><title>Trends in utilization of stored cryopreserved autologous peripheral hematopoietic cells intended for a second (or beyond) autologous hematopoietic cell transplantation in patients with multiple myeloma: a single center experience</title><author>Yassine, Farah ; Kharfan-Dabaja, Mohamed A ; Tsalantsanis, Athanasios ; Roy, Vivek ; Zubair, Abba C ; Murthy, Hemant S ; Ayala, Ernesto ; Iqbal, Madiha ; Sher, Taimur ; Ailawadhi, Sikander ; Parrondo, Ricardo D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c431t-7c37dab6720f76a09aa478ee950e8c8b1250d4ba375360614f31d0bbb3efcb713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Apheresis</topic><topic>Autografts</topic><topic>Bone marrow</topic><topic>Costs</topic><topic>Cryopreservation</topic><topic>Hematopoietic stem cells</topic><topic>Multiple myeloma</topic><topic>Patients</topic><topic>Peripheral blood</topic><topic>Stem cell transplantation</topic><topic>Sums</topic><topic>Transplantation</topic><topic>Transplants &amp; implants</topic><topic>Trends</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yassine, Farah</creatorcontrib><creatorcontrib>Kharfan-Dabaja, Mohamed A</creatorcontrib><creatorcontrib>Tsalantsanis, Athanasios</creatorcontrib><creatorcontrib>Roy, Vivek</creatorcontrib><creatorcontrib>Zubair, Abba C</creatorcontrib><creatorcontrib>Murthy, Hemant S</creatorcontrib><creatorcontrib>Ayala, Ernesto</creatorcontrib><creatorcontrib>Iqbal, Madiha</creatorcontrib><creatorcontrib>Sher, Taimur</creatorcontrib><creatorcontrib>Ailawadhi, Sikander</creatorcontrib><creatorcontrib>Parrondo, Ricardo D</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Bone marrow transplantation (Basingstoke)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yassine, Farah</au><au>Kharfan-Dabaja, Mohamed A</au><au>Tsalantsanis, Athanasios</au><au>Roy, Vivek</au><au>Zubair, Abba C</au><au>Murthy, Hemant S</au><au>Ayala, Ernesto</au><au>Iqbal, Madiha</au><au>Sher, Taimur</au><au>Ailawadhi, Sikander</au><au>Parrondo, Ricardo D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trends in utilization of stored cryopreserved autologous peripheral hematopoietic cells intended for a second (or beyond) autologous hematopoietic cell transplantation in patients with multiple myeloma: a single center experience</atitle><jtitle>Bone marrow transplantation (Basingstoke)</jtitle><addtitle>Bone Marrow Transplant</addtitle><date>2023-10-01</date><risdate>2023</risdate><volume>58</volume><issue>10</issue><spage>1130</spage><epage>1136</epage><pages>1130-1136</pages><issn>0268-3369</issn><issn>1476-5365</issn><eissn>1476-5365</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>Due to the advent of effective novel therapies for multiple myeloma (MM), the use of cryopreserved autologous peripheral blood hematopoietic cells (APBHC) for a salvage autologous transplant (auto-HCT) is in decline. We evaluated utilization trends and costs associated with cryopreserved APBHC in patients with MM. We retrospectively evaluated the clinicopathologic data from 440 patients with MM who underwent APBHC mobilization and collection at Mayo Clinic Florida between 2010 and 2019. Based on institution-specific charges as of May 2021, the cost of 1 session of APBHC collection/apheresis was $4,680 and the cost of 1 year of APBHC cryopreservation was $4,790 per patient. Out of 347 patients who had APBHC in cryopreservation, 5 (1.4%) underwent a salvage auto-HCT and 61% of patients had ≥1 excess collection sessions for APBHC that ultimately went unused. The median cost of excess collection sessions was $4,680 per patient (range, $4,680-$32,760) and the median total cost for excess collection sessions plus costs for storage was $23,840 per patient (range, $4,680-$85,450). The sum of costs of excess collection sessions was $2,077,920 and the sum of costs of cryopreservation was $5,812,665. Institutional policies regarding universal APBHC collection and long-term storage should be reevaluated in the era of novel therapeutics.</abstract><cop>England</cop><pub>Nature Publishing Group</pub><pmid>37479753</pmid><doi>10.1038/s41409-023-02035-y</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-9314-9933</orcidid><orcidid>https://orcid.org/0000-0002-8377-8111</orcidid><orcidid>https://orcid.org/0000-0002-5950-4620</orcidid><orcidid>https://orcid.org/0000-0003-4827-4740</orcidid><orcidid>https://orcid.org/0000-0001-7394-5185</orcidid><orcidid>https://orcid.org/0000-0001-6752-5440</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0268-3369
ispartof Bone marrow transplantation (Basingstoke), 2023-10, Vol.58 (10), p.1130-1136
issn 0268-3369
1476-5365
1476-5365
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10555832
source Nexis UK; Springer Link
subjects Apheresis
Autografts
Bone marrow
Costs
Cryopreservation
Hematopoietic stem cells
Multiple myeloma
Patients
Peripheral blood
Stem cell transplantation
Sums
Transplantation
Transplants & implants
Trends
title Trends in utilization of stored cryopreserved autologous peripheral hematopoietic cells intended for a second (or beyond) autologous hematopoietic cell transplantation in patients with multiple myeloma: a single center experience
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T10%3A25%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trends%20in%20utilization%20of%20stored%20cryopreserved%20autologous%20peripheral%20hematopoietic%20cells%20intended%20for%20a%20second%20(or%20beyond)%20autologous%20hematopoietic%20cell%20transplantation%20in%20patients%20with%20multiple%20myeloma:%20a%20single%20center%20experience&rft.jtitle=Bone%20marrow%20transplantation%20(Basingstoke)&rft.au=Yassine,%20Farah&rft.date=2023-10-01&rft.volume=58&rft.issue=10&rft.spage=1130&rft.epage=1136&rft.pages=1130-1136&rft.issn=0268-3369&rft.eissn=1476-5365&rft_id=info:doi/10.1038/s41409-023-02035-y&rft_dat=%3Cproquest_pubme%3E2841021263%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c431t-7c37dab6720f76a09aa478ee950e8c8b1250d4ba375360614f31d0bbb3efcb713%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2873103957&rft_id=info:pmid/37479753&rfr_iscdi=true